Crossmark

Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies

Crossref DOI link: https://doi.org/10.1007/s00277-020-04378-8

Published Online: 2021-01-03

Published Print: 2021-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gordillo, Christian A.

Parmar, Sapna

Blanco, Miranda

Delille, Elsa M.

Assal, Amer

Mapara, Markus

Reshef, Ran https://orcid.org/0000-0003-2185-9546
Funding

Funding for this research was provided by:

National Institutes of Health (R01HL14342)

U.S. Department of Defense (CA180898)
License Information

Text and Data Mining valid from 2021-01-03

Version of Record valid from 2021-01-03
More Information

Article History

Received: 30 July 2020

Accepted: 16 December 2020

First Online: 3 January 2021

Compliance with ethical standards

:

: The retrospective study was approved with waiver of informed consent by the Institutional Review Board at Columbia University Irving Medical Center.

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below